Mérieux Equity Partners and Siparex Acquire Majority Stake in Piercan
March 21, 2023
Mérieux Equity Partners' MP4 fund has signed a definitive agreement to acquire a controlling majority stake in Piercan, with Groupe Siparex and regional investor Normandie Participations investing alongside. The deal is a primary LBO that will support Piercan — a Normandy-based, global manufacturer of isolator and dry-box gloves for the pharmaceutical and nuclear industries — to improve industrial capabilities, pursue international expansion and diversify into new market segments; the founding Lucas family and other historical shareholders reinvest part of their proceeds.
- Buyers
- Mérieux Equity Partners, Siparex, Normandie Participations
- Targets
- Piercan
- Sellers
- Lucas family (founding family), Other historical shareholders
- Industry
- Medical Devices
- Location
- Normandy, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Ardian Acquires Stake in Groupe Orion
June 11, 2024
Wealth Management
Ardian has acquired a stake in France-based wealth manager Groupe Orion alongside founders Manuel Parent and Emmanuel Angelier, with Siparex ETI selling its entire holding. The investment will support Groupe Orion’s growth and consolidation strategy, accelerate product and digital development (including its Canopia solution), and back further organic and external growth initiatives.
-
Siparex ETI Acquires Majority Stake in Sintex NP (European Subsidiary of Sintex Group)
August 19, 2019
Manufacturing
Siparex ETI, with co-investors Carvest, BNP Paribas Développement, AfricInvest and Desjardins Capital, signed an agreement to acquire a majority stake in Sintex NP, the European arm of India's Sintex Group. Sintex NP is a leading European processor of polymers, composites and precision metal engineering with ~2,800 employees and €275m in sales (2018); the investment will support accelerated growth via acquisitions and international expansion, particularly into North America.
-
One Equity Partners Acquires Clayens Group
July 26, 2022
Manufacturing
One Equity Partners (OEP) has agreed to acquire Clayens NP (Clayens Group), a French contract manufacturer of high-performance polymers, composites and precision metal parts, from a group of investors led by Siparex. Siparex and other co-investors will reinvest alongside OEP and management will remain involved as minority partners; financial terms were not disclosed.
-
Ergon Acquires Majority Stake in Palex from Corpfin and Knuth Family
December 23, 2019
Healthcare Services
Ergon Capital Partners has agreed to acquire a majority stake in Palex, the leading distributor of hospital equipment, technology and solutions in Spain and Portugal, from Corpfin Capital, the Knuth family and the management team. Corpfin will retain a minority stake alongside Ergon and Palex’s management as Ergon supports the company’s national and international growth plans.
-
Fremman Acquires Majority Stake in Palex from Ergon and Corpfin
October 20, 2021
Medical Devices
Fremman has acquired a majority stake in Palex, the leading distributor of high value-added MedTech equipment and solutions in Spain and Portugal, from Ergon Capital Partners and Corpfin Capital. Management, Ergon and Corpfin will remain minority shareholders as Fremman partners with the Palex team to pursue further consolidation and geographic expansion across Iberia and Europe.
-
Ampersand Capital Partners Majority Recapitalizes Phosphorex
August 25, 2022
Healthcare Services
Ampersand Capital Partners completed a majority recapitalization of Phosphorex to provide growth capital enabling the company to build out a 30,000 sq. ft. facility and establish cGMP manufacturing capabilities for lipid nanoparticles, microspheres and other drug-delivery platforms. The investment positions Phosphorex to expand from development and analytical services into end-to-end CDMO manufacturing to better serve pharmaceutical and biotechnology clients.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.